Array BioPharma Competitors and Similar CompaniesClear all
Array BioPharma's competitors and similar companies include Durect.
 Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Cupertino, US HQ |
Employees | Employees 110 | Employees 902% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $2m (FY, 2024) |
Cost of goods | Cost of goods $59.4m (FY, 2018) | Cost of goods $78k (FY, 2024) |
Gross profit | Gross profit $114.4m (FY, 2018) | Gross profit $2m (FY, 2024) |
Net income | Net income ($147.7m) (FY, 2018) | Net income ($8.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company